Winter Course in Infectious Diseases
New date and location!
March 8-12, 2015
The Grand Summit Hotel at The Canyons Resort
Park City, Utah
Please join us for the 41st Remington Winter Course in Infectious Diseases with a new location and date. Forty years ago, this course was developed in an effort to contribute high-quality medical and scientific information and to provide continuing medical education to physicians. This high level of education has continued and has now evolved into one of the premier infectious diseases meetings in the United States. Topics will be presented in lectures, panel discussions, debates, case presentations, and question and answer sessions. Meet the Professor sessions will allow for personal exchange between participants and faculty.
Jack S. Remington, MD, FACP, FRCP
Professor Emeritus (active), Department of Medicine Division of Infectious Diseases and Geographic Medicine Stanford University School of Medicine Department of Pathology, Toxoplasma Serology Laboratory Palo Alto Medical Foundation Palo Alto, California
A.W. Karchmer, MD
Professor of Medicine Harvard Medical School Former Chief, Infectious Diseases Beth Israel Deaconess Medical Center Boston, Massachusetts
Richard P. Wenzel, MD, MSc
Professor and Former Chair Department of Internal Medicine Medical College of Virginia Virginia Commonwealth University Richmond, Virginia
Registration & Tuition
|Standing Rate for Fellows, Residents and Students*||$350|
*Criteria for Postdoctoral Fellows and Residents To be eligible for the reduced fee, you must be employed by an institution as a postdoctoral fellow who is within two years of graduation or a medical resident who is within six years of receipt of the M.D. degree. Proof of status is by letter from the head of the program on official university letterhead.
*Criteria for Student Rate Any undergraduate or pre-doctoral student requesting the student rate must provide either a legible photocopy of a current University ID or a letter on university letterhead from the department chair, indicating your status and anticipated graduation date. The University of Nebraska Medical Center, Center for Continuing Education and Winter Course in Infectious Diseases reserve the right to modify the content, faculty and activities and reserve the right to cancel this activity if necessary.
- Register Online
- Email: firstname.lastname@example.org
- Phone: Direct 303-407-3411 or Toll-free 866-413-1008
- Fax: 303-407-3416
- Mail: 600 Grant Street, Ste 510, Denver, CO 80203
If your registration must be cancelled and your request is received in writing on or before January 20, 2015, your paid tuition, less a $75 administrative fee, will be refunded. No refunds will be granted after January 20, 2015.
- Summarize best practices for treating infection in immunocompromised transplant recipients, particularly with regard to multi-drug-resistant bacterial pathogens and fungi.
- Utilize optimal infection control strategies including the use of horizontal vs vertical infection control programs.
- Examine the updated treatment guidelines for preventing and treating opportunistic infections in patients with human immunodeficiency virus infection /acquired immunodeficiency syndrome (HIV/AIDS).
- Identify treatment strategies and alternatives for drug-resistant infections such as methicillin-resistant Staphylococcus aureus (S aureus) (MRSA), vancomycin-resistant enterococci (VRE), Acinetobacter, and New Delhi metallo-β-lactamase 1 (NDM-1) producing Enterobacteriaceae, as well as infection control recommendations.
- Describe optimal infection control protocols to reduce exposure to Clostridium difficile (C difficile) and treatment strategies for initial and relapsed infections.
- Prescribe appropriate therapy for treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and infections with cirrhosis based on individual patient and disease factors.
- Apply new information in the prevention and treatment of complications of bacterial endocarditis.
- Prevent and treat influenza strains, including H5N1 and H7N9 and management of the MERS Coronavirus.
- Use pharmacokinetic/pharmacodynamic principles to achieve effective therapy against emerging antibiotic resistance and to reduce susceptibility in gram positive and gram negative pathogens.
- Evaluate options for treating cytomegalovirus infections.
- Apply new information gained from broad topic updates in areas of interest to ID specialists and internal medicine physicians, including: vaccines for travelers; severe eye and ENT infections; prosthetic joint infections; MDR tuberculosis; and community-acquired pneumonia.
Continuing Education Credit